News Release

Does freeze-thawing and IV delivery affect the therapeutic potential of mesenchymal stromal cells?

Peer-Reviewed Publication

Mary Ann Liebert, Inc./Genetic Engineering News

<em>Stem Cells and Development</em>

image: 

Stem Cells and Development is an authoritative peer-reviewed journal published 24 times per year in print and online. The Journal is dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. A complete table of contents and free sample issue may be viewed on the Stem Cells and Development website.

view more 

Credit: ©Mary Ann Liebert, Inc., publishers

New Rochelle, NY, May 2, 2016 - Before the therapeutic potential of using human tissue-derived mesenchymal stromal cells (MSC) to treat immune and degenerative diseases can be fully determined, the effects of freeze-thawing and intravenous delivery on MSC function must be understood. A new study reporting the changes in MSC gene expression associated with cryopreservation and exposure to the mouse lung is published in Stem Cells and Development, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Stem Cells and Development website until June 2, 2016.

In "Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression," Martin J. Hoogduijn and coauthors from Erasmus MC (Rotterdam, Netherlands), Lund University (Sweden), Charité Universtätsmedizin Berlin (Germany), and Karolinska Institutet (Stockholm, Sweden), exposed MSC derived from human fat tissue to a freeze-thaw cycle and analyzed the cells for changes in gene expression one hour after thawing. The researchers intravenously injected the MSC into mice, where the cells initially accumulated in the lungs. The results indicate that the lung microenvironment has a major effect on MSC gene expression, which could affect their therapeutic use for reducing inflammatory responses in immune disorders.

"At Stem Cells and Development, we are proud to publicize the careful, considered work being performed around the world by great research teams exemplified by the Hoogduijn paper, providing the rigor and characterization necessary to achieve responsible, effective translation to the clinic," says Editor-in-Chief Graham C. Parker, PhD, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI.

###

About the Journal

Stem Cells and Development is an authoritative peer-reviewed journal published 24 times per year in print and online. The Journal is dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. A complete table of contents and free sample issue may be viewed on the Stem Cells and Development website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cellular Reprogramming, Tissue Engineering, and Human Gene Therapy. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News (http://www.genengnews.com/), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.